Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Bioorg Med Chem Lett ; 29(16): 2364-2368, 2019 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-31196710

RESUMEN

Imidazoline-based small molecule inhibitors of p53-MDM2 interaction intended for the treatment of p53 wild-type tumors are the promising structures for design of anticancer drugs. Based on fragment approach we have investigated a key role of substituents in cis-imidazoline core for biological activity of nutlin family compounds. Although the necessity of the substituents in the phenyl rings of cis-imidazoline has been shown, there are no studies in which the replacements of a halogen by other substituents have been investigated. A series of simple cis-imidazoline derivatives containing halogen, hydroxy and alkoxy-substituents were synthesized. The biological activity of the compounds was studied using assays of cytotoxicity (MTT) and p53 level. It was found that the hydroxyl-derivatives were not cytotoxic whereas the alkoxy analogues were the same or more active as halogen-substituted compounds in cell viability test. The synthesized alkoxy derivatives induced an increase of p53 level and did not promote necrotic cell death in the concentration up to 40 µM.


Asunto(s)
Diseño de Fármacos , Imidazolinas/farmacología , Proteínas Proto-Oncogénicas c-mdm2/antagonistas & inhibidores , Bibliotecas de Moléculas Pequeñas/farmacología , Proteína p53 Supresora de Tumor/antagonistas & inhibidores , Células A549 , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Humanos , Imidazolinas/síntesis química , Imidazolinas/química , Estructura Molecular , Unión Proteica/efectos de los fármacos , Proteínas Proto-Oncogénicas c-mdm2/química , Bibliotecas de Moléculas Pequeñas/síntesis química , Bibliotecas de Moléculas Pequeñas/química , Relación Estructura-Actividad , Proteína p53 Supresora de Tumor/química
2.
Bioorg Med Chem ; 27(9): 1804-1817, 2019 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-30902399

RESUMEN

Glycogen synthase kinase 3ß (GSK-3ß) is a widely investigated molecular target for numerous diseases including Alzheimer's disease, cancer, and diabetes mellitus. Inhibition of GSK-3ß activity has become an attractive approach for treatment of diabetes and cancer. We report the discovery of novel GSK-3ß inhibitors of 3-arylidene-2-oxindole scaffold with promising activity. The most potent compound 3a inhibits GSK-3ß with IC50 4.19 nM. In a cell-based assay 3a shows no significant leucocyte toxicity at 10 µM and is moderately cytotoxic against A549 cells. Compound 3a demonstrated high antidiabetic efficacy in obese streptozotocin-treated rats improving glucose tolerance at a dose of 50 mg/kg body weight thus representing an interesting lead for further optimization.


Asunto(s)
Glucógeno Sintasa Quinasa 3 beta/antagonistas & inhibidores , Oxindoles/química , Inhibidores de Proteínas Quinasas/síntesis química , Células A549 , Animales , Sitios de Unión , Dominio Catalítico , Supervivencia Celular/efectos de los fármacos , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/tratamiento farmacológico , Prueba de Tolerancia a la Glucosa , Glucógeno Sintasa Quinasa 3 beta/metabolismo , Humanos , Concentración 50 Inhibidora , Simulación del Acoplamiento Molecular , Oxindoles/farmacología , Oxindoles/uso terapéutico , Inhibidores de Proteínas Quinasas/farmacología , Inhibidores de Proteínas Quinasas/uso terapéutico , Ratas , Relación Estructura-Actividad
3.
Org Biomol Chem ; 17(10): 2792-2797, 2019 03 06.
Artículo en Inglés | MEDLINE | ID: mdl-30793716

RESUMEN

Mixed simplified structures containing the paclitaxel and eleutherobin pharmacophore moieties were analyzed using molecular docking techniques and synthesized based on adamantane and 8-oxabicyclo[3.2.1]octane scaffolds. The crucial role of substituents' stereochemistry in biological activity is discussed. At micromolar concentrations the selected analogues interfered with tubulin dynamics in vitro and in a living organism. Furthermore, new compounds were cytotoxic against human tumour cell lines. The simplified eleutherobin analogues may be considered as prototypes of a new class of antitumour agents.


Asunto(s)
Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Diterpenos/síntesis química , Diterpenos/farmacología , Adamantano/química , Animales , Antineoplásicos/química , Antineoplásicos/metabolismo , Sitios de Unión , Línea Celular Tumoral , Técnicas de Química Sintética , Diterpenos/química , Diterpenos/metabolismo , Humanos , Simulación del Acoplamiento Molecular , Octanos/química , Conformación Proteica , Erizos de Mar/efectos de los fármacos , Tubulina (Proteína)/química , Tubulina (Proteína)/metabolismo
4.
Bioorg Med Chem Lett ; 22(24): 7578-81, 2012 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-23131339

RESUMEN

New 5-acetamido-substituted melatonin derivatives were efficiently synthesized in excellent yields via Knoevenagel condensation. The relative binding affinity of new synthesized compounds to MT3 receptor was tested via enzymatic assays and the X-ray structures of the most potent compounds were determined in complex with MT3.


Asunto(s)
Acetamidas/química , Melatonina/farmacología , Receptores de Melatonina/antagonistas & inhibidores , Cristalografía por Rayos X , Humanos , Ligandos , Melatonina/síntesis química , Melatonina/química , Modelos Moleculares , Estructura Molecular
5.
Acta Crystallogr Sect E Struct Rep Online ; 67(Pt 8): o2127-8, 2011 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-22091145

RESUMEN

The mol-ecule of the title compound, C(12)H(16)O(5), has crystallographically imposed mirror symmetry with the mirror plane passing through the endocyclic O atom and the mid-point of the double bond. In the crystal, mol-ecules are linked by C-H⋯O hydrogen bonds, forming chains running along the a axis.

6.
Acta Crystallogr Sect E Struct Rep Online ; 65(Pt 7): o1580, 2009 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-21582856

RESUMEN

The title compound, 3C(7)H(9)ClO(3)·CHCl(3), crystallizes with mol-ecules of 3-exo-chloro-8-oxabicyclo-[3.2.1]oct-6-ene-2,4-diol (A) and chloro-form in a 3:1 ratio, in the space group R3m. Mol-ecules of A straddle a crystallographic mirror plane, whereas the chloro-form mol-ecules (C and H atoms) lie additionally on the threefold axis. The mol-ecules of A are linked into right- and left-helical chains by means of O-H⋯O hydrogen bonds, thus forming columns running along the c axis. Six inter-penetrated columns form a channel in which the solvent mol-ecules (chloro-form) are located.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...